ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,000 | -36.4% | 94 | -20.3% | 0.00% | – |
| Q3 2021 | $11,000 | 0.0% | 118 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -75.6% | 118 | -70.5% | 0.00% | – |
| Q1 2021 | $45,000 | -97.6% | 400 | -98.3% | 0.00% | -100.0% |
| Q2 2020 | $1,844,000 | +171.6% | 23,579 | +54.3% | 0.00% | +200.0% |
| Q1 2020 | $679,000 | +24.6% | 15,285 | +19.7% | 0.00% | 0.0% |
| Q4 2019 | $545,000 | +14.7% | 12,772 | +14.9% | 0.00% | 0.0% |
| Q3 2019 | $475,000 | +90.8% | 11,113 | +209.3% | 0.00% | 0.0% |
| Q1 2019 | $249,000 | +295.2% | 3,593 | +332.4% | 0.00% | – |
| Q3 2018 | $63,000 | -54.0% | 831 | -69.2% | 0.00% | -100.0% |
| Q1 2018 | $137,000 | +53.9% | 2,696 | +87.1% | 0.01% | +50.0% |
| Q2 2017 | $89,000 | -83.4% | 1,441 | -81.8% | 0.00% | -82.6% |
| Q1 2017 | $535,000 | +5.7% | 7,898 | +9.7% | 0.02% | -23.3% |
| Q4 2016 | $506,000 | +173.5% | 7,198 | +174.9% | 0.03% | +130.8% |
| Q3 2016 | $185,000 | +224.6% | 2,618 | +124.3% | 0.01% | +225.0% |
| Q2 2016 | $57,000 | – | 1,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |